首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model
【24h】

Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model

机译:Fisher 344大鼠肿瘤模型中卵巢癌ALA-PDT的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: This study aimed to evaluate aminolevulinic acid-photodynamic therapy (ALA-PDT) in an experimental tumor model to expand the use of PDT in the treatment of ovarian cancer with peritoneal carcinosis. Materials and methods: 5-Aminolevulinic acid (ALA) (Photocure ASA, Norway) 60 mg/kg was injected in the peritoneum cavity of 45 female rats Fisher with induced peritoneal metastases of ovarian cancer. ALA-PDT was performed 4 h later with two different lasers: (1) laser diode (Diomed, Cambridge, UK), at 630nm, 100 mW/cm~2, or (2) KTP laser (Laser Quantum, Stockport, UK), 532 nm, 30 mW/cm~2. The animals were divided into five groups: LASER ALONE group, CTRL group (no cancer), NO LASER group, 1 DOSE group (PDT during 1 s) and 1.5 DOSE group (PDT during 1.5 s). Biopsies were taken 24 h after treatment. A semi-quantitative score called necrosis value (NV) was assigned to each sample that reflected the depth of the peritoneal necrosis. Results: In the first two groups, the peritoneum remained intact irrespective of the wavelength. In the 1 DOSE group, necrosis was observed for 532 nm and 630 nm. In the 1.5 DOSE group, necrosis was observed for 532 nm (NV: 3.22 ±0.83) and 630 nm (NV: 2.67±1.00) (p<0.05). The mesothelium strongly thinned out in the diffuse shape of the tumor. Conclusion: Only ALA-PDT induces tumor necrosis with either 532 nm and 630 nm and should be considered an effective therapy for micrometastasis of ovarian cancer. This preliminary study deserves further experiments.
机译:目的:本研究旨在评估氨基乙酰丙酸光动力疗法(ALA-PDT)在实验性肿瘤模型中的应用,以扩大PDT在治疗腹膜癌卵巢癌中的应用。材料和方法:将60 mg / kg的5-氨基乙酰丙酸(ALA)(挪威的Photocure ASA)注射到45只雌性大鼠Fisher诱发卵巢癌腹膜转移的腹膜腔中。 4小时后用两种不同的激光进行ALA-PDT:(1)630nm,100 mW / cm〜2的激光二极管(Diomed,Cambridge,UK)或(2)KTP激光(Laser Quantum,Stockport,UK) 532 nm,30 mW / cm〜2。将动物分为五个组:激光单独组,CTRL组(无癌症),无激光组,1个剂量组(1s期间的PDT)和1.5个剂量组(1.5s期间的PDT)。治疗后24小时进行活检。为每个反映腹膜坏死深度的样本分配一个称为坏死值(NV)的半定量评分。结果:在前两组中,无论波长如何,腹膜均保持完整。在1个DOSE组中,观察到532 nm和630 nm坏死。在1.5剂量组中,观察到532nm(NV:3.22±0.83)和630nm(NV:2.67±1.00)的坏死(p <0.05)。间皮在肿瘤的扩散形状中强烈变薄。结论:只有ALA-PDT可以诱导532 nm和630 nm的肿瘤坏死,应被认为是卵巢癌微转移的有效疗法。这项初步研究值得进一步的实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号